Hope Center Executive Committee member Philip Needleman was profiled in the April 10, 2007 issue of
National Academy of Sciences.

In the article, Needleman discusses his roots as a first-generation American attending pharmacy school;
explores his work including his discovery of the first angiotensin receptor antagonist, the beginning of his
COX-2 hypothesis, and his shift to industry after 25 years in academia.

For the complete article, click here.